- May, 6 2023
- 0 Comments
I recently came across an interesting study on the role of Baricitinib in managing fatigue associated with autoimmune diseases. As someone who experiences this exhaustion, I found it fascinating to learn that Baricitinib, a medication typically used to treat rheumatoid arthritis, could potentially alleviate fatigue. The drug works by inhibiting the Janus kinase (JAK) enzymes, thus reducing inflammation in the body. Clinical trials have shown promising results in improving patients' overall energy levels and daily function. I'm hopeful that further research will continue to shed light on this potential treatment option for those suffering from autoimmune-related fatigue.